We are pleased to announce that Benitec Biopharma has published study data using the PXB-Mouse model on the company’s website. The data were recently presented at the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL) in Shanghai in February 2017. Details of the presentation are as follows.
Presentation Title: Combinations of a DNA-Directed RNA Interference Agent with Standard of Care Drugs Results in Superior Suppression of Hepatitis B Virus (HBV) in a Chimeric Mouse Model
Presenter: Dr. David Suhy (Benitec Biopharma)